Zheng Deli, Zhao Shuai, Zhang Nana, Shi Ji
Department of Anesthesiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, China.
Department of Clinical Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, China.
Saudi J Biol Sci. 2020 Jul;27(7):1850-1855. doi: 10.1016/j.sjbs.2020.03.027. Epub 2020 Apr 10.
The purpose of the study was to investigate the effect of dexmedetomidine hydrochloride (Dex) on the recovery of cognitive function, hemodynamics, and postoperative analgesia in patients undergoing intracranial aneurysm craniotomy.
general anesthesia was performed on patients undergoing intracranial aneurysm craniotomy in neurosurgery. Patients were randomly divided into three groups: Dex 1 group (Dex dose: 1 μg/kg), Dex 2 group (Dex dose: 0.5 μg/kg), and blank control group (normal saline). The changes of heart rate, arterial pressure, intraoperative brain function index, and postoperative pain score were recorded and compared.
in Dex 1 group and Dex 2 group, the heart rate of T1 and T2 phase was significantly lower than that of T3-T7 phases (P < 0.05); compared with the control group, the heart rate of Dex 1 group and Dex 2 group was significantly lower (P < 0.05). The average arterial pressure of the control group and Dex groups was significantly different (P < 0.05). Compared with the control group, there were significant differences between Dex 1 group and Dex 2 group: S100 β protein in T7-T10, NSE (neuron specific enolase) in T9 and T10, pain score in T8, T9 and T10 after operation.
the application of Dex in the resection of intracranial aneurysms can protect the brain of patients, minimize the influence of operation on hemodynamics, and relieve postoperative pain, which is worthy of clinical application.
本研究旨在探讨盐酸右美托咪定(Dex)对颅内动脉瘤开颅手术患者认知功能恢复、血流动力学及术后镇痛的影响。
对神经外科行颅内动脉瘤开颅手术的患者实施全身麻醉。患者随机分为三组:Dex 1组(Dex剂量:1μg/kg)、Dex 2组(Dex剂量:0.5μg/kg)和空白对照组(生理盐水)。记录并比较心率、动脉压、术中脑功能指数及术后疼痛评分的变化。
Dex 1组和Dex 2组T1和T2期心率显著低于T3 - T7期(P < 0.05);与对照组相比,Dex 1组和Dex 2组心率显著降低(P < 0.05)。对照组与Dex组平均动脉压有显著差异(P < 0.05)。与对照组相比,Dex 1组和Dex 2组在术后T7 - T10期S100β蛋白、T9和T10期神经元特异性烯醇化酶(NSE)、T8、T9和T10期疼痛评分方面存在显著差异。
Dex应用于颅内动脉瘤切除术中可保护患者脑部,最大限度减少手术对血流动力学的影响,并缓解术后疼痛,值得临床应用。